Sumitomo Dainippon Pharma Co., Ltd. provided dividend guidance for the year ending March 31, 2017. For the period, the company expects to pay dividend of JPY 9.00 per share against JPY 9.00 per share paid a year ago.

The company reported consolidated earnings results for the nine months ended December 31, 2016. For the period, the company reported net sales of JPY 305,507 million compared to JPY 304,532 million a year ago. Operating income was JPY 44,241 million compared to JPY 31,086 million a year ago. Ordinary income was JPY 49,864 million compared to JPY 31,133 million a year ago. Net income attributable to owners of the parent of JPY 29,571 million compared to JPY 23,345 million a year ago. Earnings per share was JPY 74.43 compared to JPY 58.76 a year ago. Income before income taxes and minority interests was JPY 44,685 million compared to JPY 36,937 million a year ago. EBITDA was JPY 63,900 million compared to JPY 46,600 million a year ago. Return on equity was 6.4% compared to JPY 5.1% a year ago. Net cash used in operating activities was 1,800 million compared to net cash provided by operating activities of JPY 32,500 million a year ago. Capital expenditure was JPY 4,400 million compared to JPY 5,500 million a year ago.

For the fiscal year ending March 31, 2017, the company expects net sales of JPY 404,000 million, operating income of JPY 46,000 million, ordinary income of JPY 46,000 million net income attributable to owners of the parent of JPY 26,000 million and earnings per share to be JPY 65.44 compared to its previous forecast of net sales of JPY 398,000 million, operating income of JPY 46,000 million, ordinary income of JPY 44,000 million, net income attributable to owners of the parent of JPY 25,000 million and earnings per share to be JPY 62.92.